Ogawa Osamu, MD, PhD, Professor
Urology is a remarkably advancing scientific field in both clinical and research aspects. Our main interests are in urologic oncology as well as in benign diseases including: voiding function, transplantation, reproductive medicine, pediatric urology, urolithiasis. We have a long track record of the constant promotion of innovative therapies, leading to the recent introduction of robotic surgery and laparoendoscopic single-site surgery. Our basic policy is to provide highly advanced medicine to the patients, by refining the state-of-the-art knowledge and technology based on the active propulsion of research and education.
Research and EducationWe try to advance top-quality urologists who can analyze the complicated pathology of disease and then treat patients appropriately by practicing advanced medicine in an education-oriented environment. We have performed a large number of laparoscopic surgeries and can offer an optimal educational environment to young physicians trained as urologic surgeons and educators. Our education program for specialty training in cooperation with the affiliated hospitals has been professionally administered
In the research field, we promote the practical sciences, which contribute to real medical treatments, while collaborating with various domestic and foreign laboratories. More than 10 PhD students and foreign researchers in our lab, as well as several young urologists engaged in research abroad, consistently maintain our research activity amongst the top standards in the world, leading to numerous achievements in urologic oncology. More recently, we are conducting innovative research by introducing a molecular cellular biological approach into voiding function, and thus further contributing to the regenerative medicine of kidneys with iPS cells.
Group photograph of our department
Robot-assisted laparoscopic radical prostatectomy by Prof. Ogawa (①②) and recent research products in our laboratory (③④)
(①: Prof. Ogawa operating with da Vinci Surgical System, ②: Bed-side assistant staffs during robotic surgery, ③: Roles of RalGAP in bladder cancer, Saito et al, Oncogene 2013, ④: Expression profile analysis of prostate cancer using imaging mass spectrometry , Goto et al, PLos One 2014)
- Yoshikawa T, Kobori G, Goto T, Akamatsu S, Terada N, Kobayashi T, Tanaka Y, Jung G, Kamba T, Ogawa O, Inoue T. An original patient-derived xenograft of prostate cancer with cyst formation. Prostate. 2016.
- Shibasaki N, Yamasaki T, Kanno T, Arakaki R, Sakamoto H, Utsunomiya N, Inoue T, Tsuruyama T, Nakamura E, Ogawa O, Kamba T. Role of IL13RA2 in Sunitinib Resistance in Clear Cell Renal Cell Carcinoma. PLoS One. 2015;10(6):e0130980.
- Nakashima M, Matsui Y, Kobayashi T, Saito R, Hatahira S, Kawakami K, Nakamura E, Nishiyama H, Ogawa O. Urine CXCL1 as a biomarker for tumor detection and outcome prediction in bladder cancer. Cancer Biomark. 2015;15(4):357-64.
- Okinami T, Imamura M, Nishikawa N, Negoro H, Sugino Y, Yoshimura K, Kanematsu A, Hashitani H, Ogawa O. Altered detrusor gap junction communications induce storage symptoms in bladder inflammation: a mouse cyclophosphamide-induced model of cystitis. PLoS One. 2014;9(8):e104216.
- Goto T, Terada N, Inoue T, Nakayama K, Okada Y, Yoshikawa T, Miyazaki Y, Uegaki M, Sumiyoshi S, Kobayashi T, Kamba T, Yoshimura K, Ogawa O. The expression profile of phosphatidylinositol in high spatial resolution imaging mass spectrometry as a potential biomarker for prostate cancer. PLoS One. 2014;9(2):e90242.
UrologyProfessor: Osamu Ogawa
Associate Professor: Tomomi Kamba
Senior Lecturer: Takahiro Inoue・Toshinari Yamasaki
Assistant Professor: Naoki Terada・Takashi Kobayashi・Hiromitsu Negoro・Shusuke Akamatsu・Atsuro Sawada